Author:
de Kam P.-J.,Nolte H.,Good S.,Yunan M.,Williams-Herman D.E.,Burggraaf J.,Kluft C.,Adkinson N.F.,Cullen C.,Skov P.S.,Levy J.H.,van den Dobbelsteen D.J.,van Heumen E.L.G.M.,van Meel F.C.M.,Glassner D.,Woo T.,Min K.C.,Peeters P.A.M.
Funder
Merck Sharp & Dohme Corp.
Merck & Co., Inc
Merck & Co., Inc.
Subject
Anesthesiology and Pain Medicine
Reference26 articles.
1. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade;Abrishami;Cochrane Database Syst Rev,2009
2. Bridion SmPC;MSD Ltd Hoddesdon UK,2016
3. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study;de Kam;Clin Drug Investig,2010
4. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study;Peeters;Clin Drug Investig,2010
5. Allergy to low dose sugammadex;Menendez-Ozcoidi;Anaesthesia,2011
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献